NO20045065L - Nytt formatsalt av o-desmetyl-venlafaxin - Google Patents

Nytt formatsalt av o-desmetyl-venlafaxin

Info

Publication number: NO20045065L
Authority: NO; Norway
Prior art keywords: desmethyl; venlafaxine; new format; format salt; salt
Prior art date: 2002-06-10

Application number

NO20045065A

Other languages

English (en)

Norwegian (no)

Inventor

Anthony Francis Hadfield

Michael William Winkley

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-10

Filing date

2004-11-22

Publication date

2005-01-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29736291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20045065(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-11-22 Application filed by Wyeth Corp filed Critical Wyeth Corp

2005-01-07 Publication of NO20045065L publication Critical patent/NO20045065L/no

Links

KYYIDSXMWOZKMP-UHFFFAOYSA-N O-desmethylvenlafaxine Chemical compound C1CCCCC1(O)C(CN(C)C)C1=CC=C(O)C=C1 KYYIDSXMWOZKMP-UHFFFAOYSA-N 0.000 title abstract 2
150000003839 salts Chemical class 0.000 title abstract 2
239000002552 dosage form Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Gynecology & Obstetrics (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20045065A 2002-06-10 2004-11-22 Nytt formatsalt av o-desmetyl-venlafaxin NO20045065L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38732102P	2002-06-10	2002-06-10
PCT/US2003/018195 WO2003103603A2 (fr)	2002-06-10	2003-06-09	Nouveau sel de type formiate de o-desmethylvenlafaxine

Publications (1)

Publication Number	Publication Date
NO20045065L true NO20045065L (no)	2005-01-07

Family

ID=29736291

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20045065A NO20045065L (no)	2002-06-10	2004-11-22	Nytt formatsalt av o-desmetyl-venlafaxin

Country Status (20)

Country	Link
US (2)	US7001920B2 (fr)
EP (1)	EP1519720A4 (fr)
JP (1)	JP4445853B2 (fr)
KR (1)	KR20050013125A (fr)
CN (1)	CN1658861A (fr)
AR (1)	AR040177A1 (fr)
AU (1)	AU2003247515A1 (fr)
BR (1)	BR0311693A (fr)
CA (1)	CA2488613A1 (fr)
CR (1)	CR7583A (fr)
EC (1)	ECSP045491A (fr)
IL (1)	IL165584A0 (fr)
MX (1)	MXPA04012347A (fr)
NO (1)	NO20045065L (fr)
NZ (1)	NZ537142A (fr)
RU (1)	RU2004139075A (fr)
TW (1)	TW200407108A (fr)
UA (1)	UA84271C2 (fr)
WO (1)	WO2003103603A2 (fr)
ZA (1)	ZA200409981B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7579160B2 (en) *	1998-03-18	2009-08-25	Corixa Corporation	Methods for the detection of cervical cancer
US6342533B1 (en)	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) *	1999-04-06	2003-02-10	Sepracor Inc	Derivatives of venlafaxine and methods of preparing and using the same
DE60221642T3 (de)	2001-02-12	2017-10-26	Wyeth LLC (n.d.Ges.d. Staates Delaware)	O-desmethyl-venlafaxine succinat salz
TW200402289A (en) *	2002-05-17	2004-02-16	Wyeth Corp	Methods of treating gastrointestinary and genitourinary pain disorders
PE20040134A1 (es)	2002-07-25	2004-03-06	Pharmacia Corp	Forma de dosificacion de una vez al dia de pramipexol
EP1523981A1 (fr) *	2003-10-13	2005-04-20	Wyeth	Préparations à libération prolongée de la venlafaxine
WO2005077340A1 (fr)	2004-02-06	2005-08-25	Wyeth	Sels d'o-desmethylvenlafaxines multiparticulaires et leurs utilisations
NZ553561A (en) *	2004-08-13	2010-12-24	Boehringer Ingelheim Int	Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
JP2009500420A (ja) *	2005-07-06	2009-01-08	セプラコアインコーポレーテッド	エスゾピクロン及びｏ−デスメチルベンラファキシンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
GT200600396A (es) *	2005-09-07	2007-04-23		Dispositivos para la aplicacion de medicamentos transdermicos conteniendo o-desmetil venlafaxina (odv) o sus sales
GT200600397A (es) *	2005-09-07	2007-08-28		Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales
WO2009027766A2 (fr) *	2006-12-22	2009-03-05	Medichem, S.A.	Nouvelles formes solides cristallines de la base o-desvenlafaxine
SG175611A1 (en)	2007-02-21	2011-11-28	Sepracor Inc	Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof
CA2692738A1 (fr) *	2007-07-12	2009-01-15	Dr. Reddy's Laboratories, Ltd.	O-desmethylvenlafaxine
US20090076162A1 (en) *	2007-09-17	2009-03-19	Protia, Llc	Deuterium-enriched desvenlafaxine
CA2702664A1 (fr) *	2007-10-16	2009-04-23	Alphapharm Pty Ltd	Formulation pharmaceutique a liberation controlee
EP2212275A2 (fr) *	2007-10-22	2010-08-04	Actavis Group PTC EHF	Formes solides de sels de (±)-o-déméthylvenlafaxine
CA2703647A1 (fr) *	2007-10-26	2009-04-30	Generics [Uk] Limited	Procede de preparation de o-desmethylvenlafaxine
EP2085377A1 (fr) *	2008-01-29	2009-08-05	LEK Pharmaceuticals D.D.	Nouveaux sels d'O-desméthyl-venlafaxine
EP2262758A4 (fr) *	2008-03-12	2011-12-07	Reddys Lab Ltd Dr	Sels d o-desméthylvenlafaxine
IN2008CH00818A (fr) *	2008-04-01	2009-10-09	Actavis Group Ptc Ehf
EP2119696A1 (fr)	2008-05-16	2009-11-18	Krka	Préparation de sels de O-desméthylvenlafaxine
EP2119695A1 (fr)	2008-05-16	2009-11-18	Krka	Préparation de sels de O-desméthylvenlafaxine
WO2009155488A2 (fr) *	2008-06-19	2009-12-23	Segrub, Llc	Nouveau sel oxalate et nouveau cristal de o-desméthylvenlafaxine
KR101022335B1 (ko) *	2008-08-01	2011-03-22	제일약품주식회사	신규4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시 유도체 또는 이의 약학적으로 허용가능한 염, 이의제조방법 및 이를 유효성분으로 함유하는 중추신경계 질환예방 및 치료용 조성물
CN101716168B (zh) *	2008-10-09	2014-09-17	北京德众万全医药科技有限公司	一种含有去甲文拉法新的盐的药物组合物及其制备方法
EP2191822A1 (fr)	2008-11-26	2010-06-02	LEK Pharmaceuticals d.d.	Compositions pharmaceutiques à libération contrôlée comprenant de l' O-desméthyl-venlafaxine
CZ200969A3 (cs) *	2009-02-06	2010-06-30	Zentiva, K.S.	Nové soli desvenlafaxinu a zpusob jejich prípravy
EP2552419A2 (fr)	2010-03-31	2013-02-06	Wockhardt Limited	Forme pharmaceutique à libération modifiée comprenant de la desvenlafaxine ou des sels de celle-ci
CN102249936B (zh) *	2010-05-19	2014-09-17	江苏豪森医药集团有限公司	O-去甲基文拉法辛盐酸盐的水合物及其制备方法
RU2453559C1 (ru) *	2010-10-11	2012-06-20	Общество С Ограниченной Ответственностью "Ниармедик Плюс"	Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями
BR112013025766A2 (pt)	2011-04-12	2016-12-20	Lupin Ltd	composições farmacêuticas de liberação modificada de desvenlafaxina
US8481596B2 (en)	2011-06-08	2013-07-09	Lupin Limited	Polymomorph of desvenlafaxine benzoate
CN102349879B (zh) *	2011-10-14	2016-07-13	北京科信必成医药科技发展有限公司	一种去甲文拉法辛控释片及其制备方法
EP3035918B1 (fr) *	2013-08-26	2021-06-30	Amorsa Therapeutics, Inc.	Dose orale à couche unique de kétamine neuro-atténuante
CN112010772A (zh)	2016-01-26	2020-12-01	赵鸣	5-氨基酮戊酸及其衍生物的盐化合物和应用
TR201820634A2 (tr)	2018-12-27	2020-07-21	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Desvenlafaksi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE56324B1 (en)	1982-12-13	1991-06-19	American Home Prod	Phenethylamine derivatives and intermediates therefor
US4535186A (en)	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6562629B1 (en) *	1999-08-11	2003-05-13	Cedars-Sinai Medical Center	Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6342533B1 (en) *	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6197828B1 (en) *	1998-12-01	2001-03-06	Sepracor, Inc.	Derivatives of (+)-venlafaxine and methods of preparing and using the same
PL350924A1 (en)	1999-04-06	2003-02-10	Sepracor Inc	Derivatives of venlafaxine and methods of preparing and using the same
IT1308475B1 (it) *	1999-05-07	2001-12-17	Gate Spa	Motoventilatore, particolarmente per uno scambiatore di calore di unautoveicolo
AU5738700A (en) *	1999-06-15	2001-01-02	American Home Products Corporation	Enantiomers of o-desmethyl venlafaxine
US6348494B1 (en) *	2000-11-21	2002-02-19	American Home Products Corporation	Ethers of o-desmethyl venlafaxine
KR100867392B1 (ko) *	2000-08-15	2008-11-06	더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이	마이크로입자
DE60221642T3 (de)	2001-02-12	2017-10-26	Wyeth LLC (n.d.Ges.d. Staates Delaware)	O-desmethyl-venlafaxine succinat salz
CA2446904A1 (fr) *	2001-05-24	2003-04-03	Alexza Pharmaceuticals, Inc.	Administration d'esters medicamenteux par inhalation

2003
- 2003-06-09 BR BR0311693-0A patent/BR0311693A/pt not_active IP Right Cessation
- 2003-06-09 MX MXPA04012347A patent/MXPA04012347A/es active IP Right Grant
- 2003-06-09 EP EP03757455A patent/EP1519720A4/fr not_active Withdrawn
- 2003-06-09 WO PCT/US2003/018195 patent/WO2003103603A2/fr not_active Ceased
- 2003-06-09 AR ARP030102045A patent/AR040177A1/es unknown
- 2003-06-09 RU RU2004139075/04A patent/RU2004139075A/ru not_active Application Discontinuation
- 2003-06-09 JP JP2004510724A patent/JP4445853B2/ja not_active Expired - Fee Related
- 2003-06-09 US US10/457,596 patent/US7001920B2/en not_active Expired - Fee Related
- 2003-06-09 AU AU2003247515A patent/AU2003247515A1/en not_active Abandoned
- 2003-06-09 NZ NZ537142A patent/NZ537142A/en unknown
- 2003-06-09 KR KR10-2004-7019999A patent/KR20050013125A/ko not_active Ceased
- 2003-06-09 CN CN038135493A patent/CN1658861A/zh active Pending
- 2003-06-09 TW TW092115524A patent/TW200407108A/zh unknown
- 2003-06-09 CA CA002488613A patent/CA2488613A1/fr not_active Abandoned
- 2003-09-06 UA UAA200500166A patent/UA84271C2/ru unknown
2004
- 2004-11-22 NO NO20045065A patent/NO20045065L/no not_active Application Discontinuation
- 2004-11-24 CR CR7583A patent/CR7583A/es not_active Application Discontinuation
- 2004-12-06 IL IL16558404A patent/IL165584A0/xx unknown
- 2004-12-09 ZA ZA200409981A patent/ZA200409981B/xx unknown
- 2004-12-10 EC EC2004005491A patent/ECSP045491A/es unknown
2005
- 2005-10-21 US US11/256,241 patent/US7154001B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL165584A0 (en)	2006-01-15
MXPA04012347A (es)	2005-02-25
CA2488613A1 (fr)	2003-12-18
ECSP045491A (es)	2005-03-10
AU2003247515A1 (en)	2003-12-22
BR0311693A (pt)	2005-03-22
UA84271C2 (en)	2008-10-10
KR20050013125A (ko)	2005-02-02
EP1519720A2 (fr)	2005-04-06
WO2003103603A3 (fr)	2004-03-25
US7001920B2 (en)	2006-02-21
JP2005533772A (ja)	2005-11-10
ZA200409981B (en)	2010-05-26
WO2003103603A2 (fr)	2003-12-18
TW200407108A (en)	2004-05-16
AR040177A1 (es)	2005-03-16
US20060058552A1 (en)	2006-03-16
CR7583A (es)	2008-08-21
JP4445853B2 (ja)	2010-04-07
RU2004139075A (ru)	2005-06-27
NZ537142A (en)	2008-01-31
CN1658861A (zh)	2005-08-24
US7154001B2 (en)	2006-12-26
EP1519720A4 (fr)	2010-02-10
US20030236309A1 (en)	2003-12-25

Legal Events

Date	Code	Title	Description
2011-01-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20045065L (no)	2005-01-07	Nytt formatsalt av o-desmetyl-venlafaxin
CY1106952T1 (el)	2012-09-26	Ηλεκτρικο αλας της ο-απομεθυλ-βενλαφαξινης
CY1108522T1 (el)	2014-04-09	Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
NO20062504L (no)	2006-07-21	Sammensetninger og doseringsformer for forbedret absorpsjon
BRPI0417717A (pt)	2007-04-03	composto, composição farmacêutica, e, uso de um composto
SE0101387D0 (sv)	2001-04-20	Novel compounds
CY1111470T1 (el)	2015-08-05	Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
ES2196917T3 (es)	2003-12-16	Amidas heteroaromaticas como inhibidores del factor xa`.
MY136883A (en)	2008-11-28	3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
IL165262A (en)	2011-10-31	Kinase inhibitors and pharmaceutical compositions containing them
MY144659A (en)	2011-10-31	2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
EA200300334A1 (ru)	2003-12-25	Новая соль периндоприла и содержащие ее фармацевтические композиции
SE0101932D0 (sv)	2001-05-31	Pharmaceutical combinations
CY1106471T1 (el)	2012-01-25	Νεα μεθοδος συνθεσης της περινδροπριλης και των φαρμακευτικως αποδεκτων αλατων αυτης
ATE303384T1 (de)	2005-09-15	1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
NO20063308L (no)	2006-09-12	Kombinasjon av flupirtin og tramadol
ATE390128T1 (de)	2008-04-15	Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit
AR038305A1 (es)	2005-01-12	Composicion farmaceutica dispersable oralmente de perindopril
EA200501557A1 (ru)	2006-04-28	Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
EA200600898A1 (ru)	2006-10-27	Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
SE0200657D0 (sv)	2002-03-04	Novel Formulation
DE60305053D1 (de)	2006-06-08	Pyrimidinderivate als selektive cox-2-inhibitoren
EA200600456A1 (ru)	2006-08-25	Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600455A1 (ru)	2006-08-25	Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600454A1 (ru)	2006-08-25	Новый способ синтеза периндоприла и его фармацевтически приемлемых солей